Programme 11 February
The programme is subject to changes.
09:15–10:20 | Norwegian life science strong points
Norwegian biotechnology for health preparedness in a European context
?
- Jan Christian Vestre, Minister of Health and Care Services
- Tore Godal, UiO/WHO
- Rino Rappuoli, leader European Vaccine Hub (EVH)
- Bente Mikkelsen, Director Global Engagement Strategies, St.Jude Children's Research Hospital & Senior advisor Oslo Science City
- Cathrine Lofthus, Director General of Health and Chief Medical Officer Directorate of Health (moderator)
Health data and AI
- Valeria Vitelli, Professor, University of Oslo
Precision medicine
- Kjetil Tasken, Head of Institute for Cancer Research Oslo University Hospital & Professor University of Oslo
10:20–11:00 | Life science frontiers
Embracing biological complexity to lead future innovation in healthcare and research
- John Quackenbush, Professor, T.H. Chan Harvard School of Public Health
Title presentation TBA
- Jens Juul Holst, Professor, University of Copenhagen
?
11:00–11:30 | Break
11:30–12:30 | Parallel Sessions: Norwegian life science strong points
Health data and AI
AI instruments for better health: Producing algorithms that recommend, guide and perform.
AI-Driven Gene Prioritization for Complex Diseases: Accelerating the Discovery of Novel Therapeutic Targets
- Pooya Zakeri, Associate Professor, UiO
Inclusive AI for Health: Designing technology that works for everyone
- Kristin Fuglerud, Chief Research Scientist, Norwegian Computing Center
Artificial intelligence-guided ultrasound of abdominal aortic aneurisms performed in rural areas?
- Cecilie V?penstad, Senior Research Scientist, SINTEF Digital
Foundation model for interactive segmentation of 3D medical images
- Arian Ranjbar, Group Leader, Akershus University Hospital
Event organizer: SINTEF, TRUST: University of Oslo
One health
Antimicrobial resistance (AMR) risk management and systems theory applied to One Health challenges.
A systems-thinking framework for One Health research
- Lucy Robertson, Professor, NMBU
Strengthening access to priority antibiotics in a One-Health context – important for Norway, the Nordics, and Europe
- Christine ?rdal, Senior Scientist, Norwegian Institute of Public Health
Antimicrobial resistance and One Health in a circular world
- Gunhild Hageskal, Senior Research Scientist, SINTEF
Developing novel antibiotic resistance breakers
- Jethro Holter, CEO, AdjuTec Pharma
Moderator: Finn-Arne Weltzien, Director Aquaculture Division, Nofima
Event organizer: SINTEF, Norwegian University of Life Sciences (NMBU) and Legemiddelindustrien (LMI)
Precision medicine ?
Emerging technologies and partnerships for precision diagnostics and treatment.
Genomic profiling of circulating tumor DNA for therapy selection in advanced cancer”
- Ingrid Dyvik, Ph.D student, Oslo University Hospital
Synthetic Killer Cells for Precision Immunotherapy
- Karl-Johan Malmberg, Group Leader, Oslo University Hospital
?
Title presentation TBA
- Erik Sollig?rd, Professor & Deputy Director research, Norwegian University of Science and Technology
How can a private public collaboration with modern profiling on archived tumour-tissue increase the value of Norwegian health-data
- Steinar Thoresen, Medical Director and Co-Founder, Nordic RW
Moderator: Jutta Heix, Head of International Affairs, Oslo Cancer Cluster
The programme will be updated soon.
Event organizer: Oslo University Hospital, Oslo Cancer Cluster and LMI
11:30–12:45 | Young Talents Inspirational Talks
The programme will be updated soon.
12:30–13:30 Lunch
13:30–15:30 | Afternoon Sessions
13:30–15:00 Young Talents Network Meetings
You will have the opportunity to meet representatives from companies.?
Note that you need to register for Network meetings in order to attend (same registration form).
The programme will be updated soon.
?
13:30–14:30 Health Data 2026?
This session will be held in Norwegian.
Using health data from hospitals for research and innovation in collaboration with industry.
Go to the programme
Organizer: LMI
14:30–15:30 The Life Science Building: New opportunities research-driven value creation through collaboration
This session will be held in Norwegian.
How can the new building provide new opportunities for research, education and innovation; serve as a resource for the region and Norway; and contribute to societal value creation?
Go to the programme
Organizer: UiO Growth House
13:30–13:40 Talk by Toby Richardson, Johnson & Johnson
Senior Director, External Scientific Innovation for Johnson & Johnson EMEA
13:45–15:00 Pitching Session
Join when startup companies and innovation projects pitch their business idea.
Startups and innovation projects will be announced later
Panel will be announced later
Host: Morten Egeberg, Leader SPARK Norway and Administrative Leader UiO:Life Science